Evidence map›Paper›PMID 40309506›Full record

ArticleFrontiers in bioengineering and biotechnology2025

Biomechanical and histomorphometric characterization of the melatonin treatment effect in the carotid artery subjected to hypobaric hypoxia.

Eugenio Rivera, Alvaro Navarrete, Claudio M Garcia-Herrera, Leonardo Gordillo, Enrique Cerda, Diego J Celentano, Alejandro Gonzalez-Candia, Emilio A Herrera

Abstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Eugenio RiveraDepartamento de Ingeniería Mecánica, Universidad de Santiago de Chile, Santiago, Chile.
Alvaro NavarreteDepartamento de Ingeniería Mecánica, Universidad de Santiago de Chile, Santiago, Chile.
Claudio M Garcia-HerreraDepartamento de Ingeniería Mecánica, Universidad de Santiago de Chile, Santiago, Chile.
Leonardo GordilloDepartamento de Física, Universidad de Santiago de Chile, Santiago, Chile.
Enrique CerdaDepartamento de Física, Universidad de Santiago de Chile, Santiago, Chile.
Diego J CelentanoDepartment of Mechanical and Metallurgical Engineering, Pontificia Universidad Católica de Chile, Santiago, Chile.
Alejandro Gonzalez-CandiaInstitute of Health Sciences, Universidad de O'Higgins, Rancagua, Chile.
Emilio A HerreraPathophysiology Program, Faculty of Medicine, Institute of Biomedical Sciences (ICBM), Universidad de Chile, Santiago, Chile.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aims to assess the efficacy of melatonin in mitigating the adverse effects of hypobaric hypoxia on the cardiovascular system of neonatal lambs (30 days old). Two groups were considered for this purpose: (i) Melatonin-treated group (N = 5) and (ii) Control group (N = 6) without treatment. All subjects were exposed to hypobaric hypoxia during gestation and perinatal periods, with melatonin administered after birth. The study focused on the carotid artery, a known predictor of cardiovascular risk. Biomechanical tests, morphometric, and histological measurements were conducted, and a numerical model was developed based on the biomechanical data. Key findings showed remodeling effects: Firstly, a realignment of collagen fibers towards a longitudinal direction was observed with melatonin treatment, similar to non-hypoxic arteries. Second, changes in residual stress and

Indexed as

biomechanical testsbiomechanicscarotid arteryfinite element methodhypobaric hypoxiamelatonin

Identifiers

PMID40309506
PMCPMC12041024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.